Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 1
2015 2
2016 2
2017 1
2022 1
2023 3
2024 3
2025 3
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean draganamaric (2 results)?
Attitudes toward Death among Health Care Professionals in the Balkan Region.
Kovacevic T, Zaric B, Djekic Malbasa J, Bokan D, Nikolin B, Bursac D, Simurdic P, Stojsic V, Stojanovic G, Maric D. Kovacevic T, et al. Among authors: maric d. Curr Oncol. 2024 Jun 16;31(6):3350-3360. doi: 10.3390/curroncol31060255. Curr Oncol. 2024. PMID: 38920738 Free PMC article.
Immunofluorescence-Based Assay for High-Throughput Analysis of Multidrug Resistance Markers in Non-Small Cell Lung Carcinoma Patient-Derived Cells.
Dinić J, Podolski-Renić A, Dragoj M, Jovanović Stojanov S, Stepanović A, Lupšić E, Pajović M, Jovanović M, Petrović Rodić D, Marić D, Ercegovac M, Pešić M. Dinić J, et al. Among authors: maric d. Diagnostics (Basel). 2023 Dec 7;13(24):3617. doi: 10.3390/diagnostics13243617. Diagnostics (Basel). 2023. PMID: 38132201 Free PMC article.
Multidrug-Resistant Profiles in Non-Small Cell Lung Carcinoma Patient-Derived Cells: Implications for Personalized Approaches with Tyrosine Kinase Inhibitors.
Dinić J, Dragoj M, Jovanović Stojanov S, Stepanović A, Lupšić E, Pajović M, Mohr T, Glumac S, Marić D, Ercegovac M, Podolski-Renić A, Pešić M. Dinić J, et al. Among authors: maric d. Cancers (Basel). 2024 May 23;16(11):1984. doi: 10.3390/cancers16111984. Cancers (Basel). 2024. PMID: 38893104 Free PMC article.
Real World Data on the Efficacy of Brigatinib in ALK-Positive Non-Small Cell Lung Cancer: A Single-Center Experience.
Ćeriman Krstić V, Samardžić N, Stjepanović M, Popević S, Adžić-Vukičević T, Glumac S, Stević R, Marić D, Velinović M, Jovanović M, Ilić B, Gajić M, Čolić N, Lukić K, Maračić BM, Stamenić S, Radovanović IS, Lazović JM. Ćeriman Krstić V, et al. Among authors: maric d. Cancers (Basel). 2025 Sep 21;17(18):3084. doi: 10.3390/cancers17183084. Cancers (Basel). 2025. PMID: 41008926 Free PMC article.
15 results